Clinical Trials
3 trialsNCT02709889 2020-10-19
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
AbbVie
Phase 1/2 Terminated
NCT00629473 2017-11-22
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
Celgene
Phase 1 Completed
NCT02862145 2016-09-27
MRX34-102
Mirna Therapeutics, Inc.
Phase 1/2 Withdrawn